{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:38:40Z","timestamp":1761709120833,"version":"3.37.3"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Mundipharma"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1041472","1073858"],"award-info":[{"award-number":["1041472","1073858"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Substance Misuse Prevention and Service Improvements Grant Fund"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2015,11]]},"abstract":"Abstract<\/jats:title>Introduction and Aims<\/jats:title>The harms associated with non\u2010medical use of pharmaceutical opioid analgesics are well established; however, less is known about the characteristics and drug\u2010use patterns of the growing and hidden populations of people using pharmaceutical opioids illicitly, including the frequency of pharmaceutical opioid injection. This paper aimed to undertake a detailed examination of jurisdictional differences in patterns of opioid use among a cohort of people who regularly tamper with pharmaceutical opioids in A<\/jats:styled-content>ustralia.<\/jats:p><\/jats:sec>Design and Methods<\/jats:title>Data were drawn from the N<\/jats:styled-content>ational O<\/jats:styled-content>pioid M<\/jats:styled-content>edications A<\/jats:styled-content>buse D<\/jats:styled-content>eterrence study. The cohort was recruited from N<\/jats:styled-content>ew S<\/jats:styled-content>outh W<\/jats:styled-content>ales (NSW<\/jats:styled-content>; n<\/jats:italic>\u2009=<\/jats:italic>\u2009303), S<\/jats:styled-content>outh A<\/jats:styled-content>ustralia (SA<\/jats:styled-content>; n<\/jats:italic>\u2009=<\/jats:italic>\u2009150) and T<\/jats:styled-content>asmania (TAS<\/jats:styled-content>; n<\/jats:italic>\u2009=<\/jats:italic>\u2009153) to participate in face\u2010to\u2010face structured interviews collecting data on use of pharmaceutical opioids, benzodiazepines, other sedative drugs and illicit substances, as well as the harms associated with substance use.<\/jats:p><\/jats:sec>Results<\/jats:title>TAS<\/jats:styled-content> participants reported greater use and injection of certain pharmaceutical opioids (particularly morphine and methadone tablets), and limited heroin use, with lower rates of engagement in opioid substitution treatment, compared with NSW<\/jats:styled-content> participants. NSW<\/jats:styled-content> participants were more socially disadvantaged and more likely to report risky injecting behaviours and injecting\u2010related injuries and diseases compared with SA<\/jats:styled-content> and TAS<\/jats:styled-content> participants. SA<\/jats:styled-content> participants reported greater rates of pain conditions, greater use of pain\u2010based services, as well as broader use of pharmaceutical opioids in regards to forms and route of administration, compared with NSW<\/jats:styled-content> participants.<\/jats:p><\/jats:sec>Discussion and Conclusions<\/jats:title>Distinct jurisdictional profiles were evident for people who tamper with pharmaceutical opioids, potentially reflecting jurisdictional differences in prescribing regulatory mechanisms and addiction treatment models [Peacock A, Bruno R, Cama E, Kihas I, Larance B, Lintzeris N, Hordern A, White N, Ali R, Degenhardt L. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.<\/jats:italic> Drug Alcohol Rev 2015;34:611\u201322]<\/jats:italic><\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.12279","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:58:45Z","timestamp":1434614325000},"page":"611-622","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids"],"prefix":"10.1111","volume":"34","author":[{"given":"Amy","family":"Peacock","sequence":"first","affiliation":[{"name":"School of Medicine University of Tasmania Hobart Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-833X","authenticated-orcid":false,"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[{"name":"School of Medicine University of Tasmania Hobart Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cama","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Kihas","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briony","family":"Larance","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"Sydney Medical School Sydney University Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Hordern","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-8778","authenticated-orcid":false,"given":"Nancy","family":"White","sequence":"additional","affiliation":[{"name":"University of Adelaide Adelaide Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[{"name":"University of Adelaide Adelaide Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,18]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12551"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61138-0"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12446"},{"key":"e_1_2_8_5_1","unstructured":"Australian Institute of Health and Welfare.2010 National Drug Strategy Household Survey report. Canberra: Australian Institute of Health and Welfare 2011."},{"key":"e_1_2_8_6_1","unstructured":"StaffordJ BurnsL.Australia Drug Trends 2013: Findings from the Illicit Drug Reporting System (IDRS). Sydney: NDARC University of New South Wales 2014."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja10.11450"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ip.2010.029611"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2011.01703.x"},{"key":"e_1_2_8_10_1","unstructured":"Australian Crime Commission.2012\u20132013 Illicit Drug Report Data. ACT 2014."},{"key":"e_1_2_8_11_1","unstructured":"National Drug and Alcohol Research Centre.A Review of Opioid Prescribing in Tasmania: A Blueprint for the Future. Sydney: NDARC University of New South Wales 2012."},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230600868504"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb139320.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12746"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.168"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2003.12.005"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.03.006"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"e_1_2_8_20_1","first-page":"9","article-title":"The primary care PTSD screen (PC\u2010PTSD): development and operating characteristics","volume":"9","author":"Prins A","year":"2004","journal-title":"Int J Psychiatry Clin Pract"},{"volume-title":"The Alcohol Use Disorders identification Test. Guidelines for Use in Primary Care","year":"2001","author":"Babor TF","key":"e_1_2_8_21_1"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1995.9056072.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02953.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.08.016"},{"key":"e_1_2_8_25_1","unstructured":"Australian Institute of Health and Welfare.National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD).2014."},{"key":"e_1_2_8_26_1","unstructured":"NSW Ministry of Health.New South Wales Opioid Treatment Program: clinical guidelines for methadone and buprenorphine treatment of opioid dependence: NSW Ministry of Health 2006."},{"key":"e_1_2_8_27_1","unstructured":"South Australia Health.Policy for non\u2010supervised dosing of methadone and buprenorphine in drug treatment programs: South Australia Health 2012."},{"key":"e_1_2_8_28_1","unstructured":"Department of Health and Human Services.Tasmanian Opioid Pharmacotherapy Program Policy and Clinical Practice Standards. Hobart: Tasmanian Government 2012."},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.10785"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.12279","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.12279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T17:05:42Z","timestamp":1694451942000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.12279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,18]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1111\/dar.12279"],"URL":"https:\/\/doi.org\/10.1111\/dar.12279","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"type":"print","value":"0959-5236"},{"type":"electronic","value":"1465-3362"}],"subject":[],"published":{"date-parts":[[2015,6,18]]},"assertion":[{"value":"2014-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-03-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}